Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246829.RAostL9WNELKdoG-fTrlrCmR4XAMsi2mU6VB5Qw6ORNt4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246829.RAostL9WNELKdoG-fTrlrCmR4XAMsi2mU6VB5Qw6ORNt4130_assertion type Assertion NP1246829.RAostL9WNELKdoG-fTrlrCmR4XAMsi2mU6VB5Qw6ORNt4130_head.
- NP1246829.RAostL9WNELKdoG-fTrlrCmR4XAMsi2mU6VB5Qw6ORNt4130_assertion description "[We found that AGO1 rs595961 (?(2) = 9.066, p = 0.003; odds ratio [OR] = 0.459, 95% confidence interval [CI]: 0.275-0.768) and AGO2 rs4961280 (?(2) = 4.111, p = 0.043; OR = 0.590, 95% CI: 0.353-0.986) G alleles have significantly altered the risk for AD, and also there is a significant association of GEMIN4 rs910924 (?(2) = 5.291, p = 0.021; OR = 1.913, 95% CI: 1.094-3.344) T allele with the risk for AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246829.RAostL9WNELKdoG-fTrlrCmR4XAMsi2mU6VB5Qw6ORNt4130_provenance.
- NP1246829.RAostL9WNELKdoG-fTrlrCmR4XAMsi2mU6VB5Qw6ORNt4130_assertion evidence source_evidence_literature NP1246829.RAostL9WNELKdoG-fTrlrCmR4XAMsi2mU6VB5Qw6ORNt4130_provenance.
- NP1246829.RAostL9WNELKdoG-fTrlrCmR4XAMsi2mU6VB5Qw6ORNt4130_assertion SIO_000772 25495208 NP1246829.RAostL9WNELKdoG-fTrlrCmR4XAMsi2mU6VB5Qw6ORNt4130_provenance.
- NP1246829.RAostL9WNELKdoG-fTrlrCmR4XAMsi2mU6VB5Qw6ORNt4130_assertion wasDerivedFrom befree-2016 NP1246829.RAostL9WNELKdoG-fTrlrCmR4XAMsi2mU6VB5Qw6ORNt4130_provenance.
- NP1246829.RAostL9WNELKdoG-fTrlrCmR4XAMsi2mU6VB5Qw6ORNt4130_assertion wasGeneratedBy ECO_0000203 NP1246829.RAostL9WNELKdoG-fTrlrCmR4XAMsi2mU6VB5Qw6ORNt4130_provenance.